Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2021 Oct 7;73(11):1577–1582. doi: 10.1002/acr.24395

Table 3:

Rate ratio comparing those with prior disease manifestation to those without with respect to incidence of cachexia

Prior Disease Manifestation Crude Rate Ratio (95% CI) P-value Adjusted Rate Ratio* (95% CI) P-value
Skin 1.08 (0.90, 1.30) 0.38 1.10 (0.92, 1.31) 0.32
Musculoskeletal 1.03 (0.83, 1.27) 0.78 1.01 (0.81, 1.25) 0.93
Serositis 1.22 (1.08, 1.38) 0.001 1.15 (1.01, 1.30) 0.03
Neurologic 1.09 (0.97, 1.22) 0.13 1.07 (0.96, 1.20) 0.23
Renal 1.42 (1.27, 1.58) <0.001 1.33 (1.19, 1.49) <0.001
Hematologic 1.32 (1.13, 1.56) 0.001 1.26 (1.07, 1.48) 0.01
Vasculitis 1.36 (1.18, 1.57) <0.001 1.28 (1.11, 1.48) 0.001
Constitutional 1.00 (0.78, 1.29) 0.97 1.40 (1.25, 1.56) <0.001
*

Adjusted by current steroid use